Today: 30 April 2026
LivePerson (LPSN) Soars After Citron Shout‑Out: Q3 Beat, Guidance Lift, and AI ‘Conversation Simulator’ Fuel Rally — 11/11/2025

LivePerson (LPSN) Soars After Citron Shout‑Out: Q3 Beat, Guidance Lift, and AI ‘Conversation Simulator’ Fuel Rally — 11/11/2025

LivePerson, Inc. (NASDAQ: LPSN) jumped sharply on Tuesday after a bullish note from Citron Research added fuel to momentum from the company’s third‑quarter results released late Monday. As of mid‑afternoon, shares traded near $6.25 and touched an intraday high of $7.50 (roughly +43% versus Monday’s close), reflecting investor enthusiasm around an earnings beat and the company’s new Conversation Simulator AI product.

What’s moving the stock today (Nov. 11)

  • Citron catalyst: Citron Research highlighted LivePerson’s stronger‑than‑expected Q3 print and argued the market underestimates the company’s AI pipeline, spotlighting the new Conversation Simulator and enterprise traction. That commentary helped send LPSN sharply higher in early trading.
  • Fresh off earnings: On Nov. 10, LivePerson reported Q3 revenue of $60.2M (–19% y/y) and adjusted EBITDA of $4.8M, both above the high end of guidance. Management also detailed 28 total deals in the quarter and rising average revenue per customer.

Key numbers & guidance

  • Revenue: $60.2M (–19% y/y).
  • Adjusted EBITDA: $4.8M.
  • Net income (GAAP): $8.7M, primarily reflecting a gain related to a troubled‑debt restructuring.
  • Cash & equivalents: $106.7M at Sept. 30, 2025.
  • Q4 outlook: Revenue $50.5M–$55.5M; adjusted EBITDA –$0.3M to $4.7M.
  • Full‑year 2025 outlook: Revenue $235M–$240M; adjusted EBITDA $7.5M–$12.5M (raised from prior FY range).

Why “raised”: In August, LivePerson’s full‑year 2025 outlook called for revenue of $230M–$240M and adjusted EBITDA of –$3M to $7M. Monday’s update increases the low end of the revenue range to $235M and lifts the adjusted EBITDA range to $7.5M–$12.5M. PR Newswire

Product momentum: Conversation Simulator

Last week, LivePerson launched Conversation Simulator, a vendor‑agnostic testing and governance environment designed to de‑risk generative AI deployments by letting enterprises test, train, and validate AI (and human) agents before they touch customers. The company says Telstra is already using the product and seeing early results. Citron’s note pointed to this tool as a core part of the bull thesis.

Strategic and financial context

  • Deals and mix: The company signed 28 deals in Q3 (26 expansions/renewals, 2 new logos), and TTM ARPC increased 5.6% to $665K, signaling deeper wallet share with remaining customers despite top‑line pressure.
  • Balance sheet actions: LivePerson’s reported GAAP profit for the quarter was largely driven by the troubled‑debt restructuring gain linked to its deleveraging program earlier this year, while cash ended the quarter at $106.7M.
  • Share mechanics: The company completed a 1‑for‑15 reverse stock split on Oct. 13, 2025; per‑share figures are retroactively adjusted. That context matters when comparing historical share prices or EPS.

The big picture for LPSN

LivePerson is pushing to stabilize revenue while pivoting to predictable, governed conversational AI—a theme management emphasized alongside its Google partnership and cloud migrations. Despite lower year‑over‑year revenue, beats on revenue and adjusted EBITDA guidance, a higher FY adjusted EBITDA range, and tangible product updates are the near‑term drivers behind today’s sharp move.

What to watch next

  1. Q4 execution vs. a conservative guide: Can LivePerson hit the top end of its Q4 ranges and carry momentum into 2026?
  2. Conversation Simulator adoption: Additional named customers, proof points, or compliance use‑cases could further validate demand.
  3. Profitability trajectory: The widened FY25 adjusted EBITDA range implies improving operating discipline; watch for sustained positive free cash flow.

Sources (today and this week)

  • Stock move (real‑time): Web market data for LPSN (price, high/low, intraday move).
  • Citron reaction piece (today, Nov. 11): Investing.com coverage of Citron’s bullish note and today’s surge.
  • Q3 2025 earnings press release (Nov. 10): Revenue/EBITDA beats, guidance, deal metrics, cash, and reverse split footnote.
  • FY guidance change context (Aug. 11 vs. Nov. 10): Prior and updated 2025 outlook from PR Newswire releases.
  • Product launch (Nov. 6): PR Newswire — Conversation Simulator, enterprise use and claims.

Editor’s note: This article is for informational purposes only and is not investment advice. Always do your own research.

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Sea Limited (SE) Q3 2025: Revenue Jumps 38% to $6B; EPS Misses Street View as Shopee Outlook Raised Above 25%
Previous Story

Sea Limited (SE) Q3 2025: Revenue Jumps 38% to $6B; EPS Misses Street View as Shopee Outlook Raised Above 25%

IBM Stock Soars on AI, Quantum, and Cloud Hype – Is the Rally Sustainable?
Next Story

IBM Stock Today (11/11/2025): Price Action, Fresh AI Partnerships, and Design Win Put IBM in Focus

Go toTop